Feb 3 • 17:17 UTC 🇩🇰 Denmark Politiken

Novo lander growth at six percent with annual report

Novo Nordisk reported a revenue of over 309 billion kroner in 2025, marking a growth of six percent, though the growth in sales of weight loss drugs slowed in the fourth quarter, despite Wegovy sales exceeding expectations.

📡 Similar Coverage